Press releases

Read more:

Search
Categories

2019

Nanologica enters into an agreement with Chinese Yunbo Technology (Beijing) Co. for the delivery of preparative chromatography media to a value of approximately...
Nanologica announces that the United States Patent and Trademark Office has issued Nanologica’s patent titled ”Improved method for stem cell...
Nanologica will be attending BIO-Europe Spring 2019 in Vienna, Mar. 25 – 27 to meet with potential pharmaceutical partners regarding co-development...
Nanologica and AstraZeneca have entered into an agreement for the evaluation of Nanologica’s pending patented technology, applied to AstraZeneca...

2018

One of Nanologica’s patent applications has today become public. Through the patent, Nanologica is seeking to strengthen and expand its technology...
2018-10-03 11:36 Exclusivity agreement for the Chinese market Regulatory MAR
Nanologica AB (publ) has today entered into a five-year distribution agreement with Yunbo Technology (Beijing) Co. for the Chinese market. The agreement...
Vicore Pharma AB (publ) will decide on an acquisition of INIM Pharma AB, where Nanologica AB is a minor shareholder, in an Extraordinary General Meeting...
Nanologica has signed a three-year supply agreement with Chinese SinoUnison who focuses on analytical services within food control. Nanologica will supply...
Nanologica licenses part of its technology platform to INIM Pharma AB, a company set up by HealthCap. The new company is focused on certain therapeutic...
Länk till presentationen